Skip to main content

Table 2 Response of patients with measurable disease

From: Survival comparison of first-line treatment regimens in patients with braf-mutated advanced colorectal cancer: a multicenter retrospective study

Response

All

Chemotherapy

Chemo + bevacizumab

n = 61

n = 31

n = 30

PR

10

3

7

SD

27

8

19

PD

13

10

3

Missing

11

10

1

ORR

20%

14.30%

24.10%

DCR

74%

52.40%

89.70%

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us